Modelling approach for separating blood time-activity curves in positron emission tomographic studies.

A modelling approach is developed to generate the full time course of an injected radiotracer and its labelled metabolites in plasma/blood, based on measurements of the total radioactivities in withdrawn plasma/blood samples. A compartmental model is used to describe the conversion of an injected tracer to its metabolites in the body. The model equation is formulated with the total radioactivity concentration curve as the input function. The utility and characteristics of the approach in quantitative positron emission tomographic (PET) studies are shown with two examples. In the first example, using the tracer 6-[18F]fluoro-L-dopa (FDOPA), the approach is shown to derive the full time course of plasma FDOPA and its metabolites. In the second example of dynamic 15O oxygen PET, the approach is used to solve a deconvolution problem to give separated time-activity curves of 15O oxygen and 15O water in blood. The modelling approach improves the separation of blood/plasma time-activity curves and leads to better quantitative interpretation of PET results.

[1]  Solution to the inverse problem of the 1‐D wave equation , 1989 .

[2]  R. Frackowiak,et al.  Quantitative Measurement of Regional Cerebral Blood Flow and Oxygen Metabolism in Man Using 15O and Positron Emission Tomography: Theory, Procedure, and Normal Values , 1980, Journal of computer assisted tomography.

[3]  J C Mazziotta,et al.  Estimation of Local Cerebral Protein Synthesis Rates with L-[1-11C]Leucine and PET: Methods, Model, and Results in Animals and Humans , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  A. Luxen,et al.  Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats. , 1990, Biochemical pharmacology.

[5]  C J Thompson,et al.  Estimation of Cerebral Oxygen Utilization Rate by Single-Bolus 15O2 Inhalation and Dynamic Positron Emission Tomography , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  C. Nahmias,et al.  Metabolites of 6-[18F]fluoro-L-dopa in human blood. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  C. Nahmias,et al.  Dopamine visualized in the basal ganglia of living man , 1983, Nature.

[8]  J. Nutt,et al.  Clinical and biochemical studies with controlled‐release levodopa/carbidopa , 1986, Neurology.

[9]  J C Mazziotta,et al.  6‐[18F]Fluoro‐L‐DOPA probes dopamine turnover rates in central dopaminergic structures , 1990, Journal of neuroscience research.

[10]  M E Raichle,et al.  Brain oxygen utilization measured with oxygen-15 radiotracers and positron emission tomography: generation of metabolic images. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  A. Luxen,et al.  The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans. , 1990, Life sciences.

[12]  M E Phelps,et al.  Model Dependency and Estimation Reliability in Measurement of Cerebral Oxygen Utilization Rate with Oxygen-15 and Dynamic Positron Emission Tomography , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  C. Patlak,et al.  Nigrostriatal function in humans studied with positron emission tomography , 1989, Annals of neurology.